Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: A meta-analysis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Li, Ya Feng ^a   Zhu, Xiao Ming ^b   Liu, Fan ^c   Xiao, Chuan Shi ^a   Bian, Yun Fei ^a   Li, Hong ^a   Cai, Jun ^b   Li, Rong Shan ^a   Yang, Xin Chun ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; PERINDOPRIL; TRANDOLAPRIL;

ACE GENE; AGE; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); COUGHING; DATA ANALYSIS; EFFECT SIZE; FOLLOW UP; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; META ANALYSIS; PREDICTION; RACE DIFFERENCE; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION;

ALLELES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; COUGH; GENE DELETION; GENE FREQUENCY; GENOTYPE; HUMANS; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 84862558403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037396     Document Type: Article

References (51)

1. The SOLVD Investigators, (1997) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302.
2. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 812-828.
3. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429-1435.
4. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, et al. (1992) Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N Engl J Med 327: 669-677.
5. Guidelines Subcommittee (1999) World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17: 151-183.
6. Fuller RW, Choudry NB, (1987) Increased cough reflex associated with angiotensin-converting enzyme inhibitor cough. Br Med J 295: 1025-1026.
7. Bucknall CE, Neilly JB, Carter R, Stevenson RD, Semple PF, (1988) Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. Br Med J 296: 86-88.
8. Yeo WW, Ramsay LE, (1990) Persistent dry cough with enalapril: Incidence depends on method used. J Hum Hypertens 4: 517-520.
9. Israili ZH, Hall WD, (1992) Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 117: 234-242.
10. Woo J, Chan TY, (1991) A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract 45: 178-180.
11. Woo KS, Nicholls MG, (1995) High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol 40: 141-144.
12. Woo KS, Norris RM, Nicholls G, (1995) Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 75: 967-968.
13. Jaspard E, Wei L, Alhenc-Gelas F, (1993) Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II) studies with bradykinin and other natural peptides. J Biol Chem 268: 9496-9503.
14. Jaspard E, Alhenc-Gelas F, (1995) Catalytic properties of the two active sites of angiotensin I-converting enzyme on the cell surface. Biochem Biophys Res Commun 211: 528-534.
15. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, et al. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346.
16. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene control plasma ACE levels. Am J Hum Genet 51: 197-205.
17. Danilov S, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, et al. (1996) Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies. J Hypertens 14: 719-727.
18. Furuya K, Yamaguchi E, Hirabayashi T, Itoh A, Hizawa N, et al. (1994) Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough. Lancet 343: 354.
19. Lee YJ, Tsai JC, (2001) Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor-58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 50: 1346-1350.
20. Chadwick IG, Yeo WW, Higgins KS, Jackson PR, Ramsay LE, et al. (1994) ACE inhibitors, cough, and genetics. Lancet 343: 740-741.
21. Kreft-Jais C, Laforest L, Bonnardeaux A, Dumont C, Plouin PF, et al. (1994) ACE inhibitors, cough, and genetics. Lancet 343: 740.
22. Zee RY, Rao VS, Paster RZ, Sweet CS, Lindpaintner K, (1998) Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis. Hypertension 31: 925-928.
23. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
24. Higgins JP, Thompson SG, et al. (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
25. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
26. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, (2011) ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One 6: e19599.
27. Kim JH, Kim KK, Jeong HC, Lee SY, Kwon YH, et al. (1999) Correlation between angiotensin-converting enzyme (ACE) inhibitor induced dry cough and ACE gene insertion/deletion (I/D) polymorphism. Tubercul Respirat Dis 46: 241-250.
28. Wu J, Zhao W, (1999) [The Association between the Gene Polymorphism of Angiotensin Converting Enzyme (ACE) and ACE inhibitor-induced cough]. DOI: CNKI:SUN:YIYA.0.1999-03-002. Chinese.
29. Mukae S, Itoh S, Aoki S, Iwata T, Nishio K, et al. (2002) Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough. J Hum Hypertens 16: 857-863.
30. Wang H, (2003) [Linkage Analysis of the Association of Genetic Polymorphisms of Angiotensin Converting Enzyme and Bradykinin B2 Receptor with ACE Inhibitors-Induced Cough]. DOI: CNKI:CDMD:2.2003.099302. Chinese.
31. Ye RJ, He QY, Gai J, Shang Y, (2004) [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension]. Zhonghua Jie He He Hu Xi Za Zhi 27: 581-4. Chinese.
32. Shi M, Liu D, Hu K, Chen G, Yang J, (2008) [Relationship Between Polymorphism of Angiotensin Converting Enzyme Gene and Cough Caused by Angiotensin Converting Enzyme Inhibitors]. DOI: CNKI:SUN:HBYK.0.2008-01-026. Chinese.
33. Grilo A, Sáez-Rosas MP, Santos-Morano J, Sánchez E, Moreno-Rey C, et al. (2011) Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough. Pharmacogenet Genomics 21: 10-17.
34. Yeo WW, Higgins KS, Morice AH, Jackson PR, Peake IR, et al. (1992) Investigation of relation between ACE gene polymorphism and ACE inhibitor cough. Proceedings of the BPS, 9-11 September 1992.
35. Okumura H, Nishimura E, Kariya S, Ohtani M, Uchino K, et al. (2001) [No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients]. Yakugaku Zasshi 121: 253-257. Japanese.
36. Yang SM, He QY, Miao YD, (2003) [The relationship between polymorphism of angiotensin converting enzyme gene and cough caused by angiotensin converting enzyme inhibitors]. Zhonghua Jie He He Hu Xi Za Zhi 26: 203-205. Chinese.
37. Lu J, Li LM, Zhan SY, Yang HY, Li XH, et al. (2003) [Study on candidate genes of benazepril related cough in Chinese hypertensives]. Zhonghua Liu Xing Bing Xue Za Zhi 24: 498-502. Chinese.
38. Tang XH, Yuan H, Li LJ, Huang J, Yang GP, et al. (2008) [A study on the association between the therapeutic effect of Captopril, induced cough and angiotensin-converting enzyme gene I/D polymorphism and its possible mechanism]. Chin J Arterioscler 16: 376-380. Chinese.
39. Woo SW, Bang S, Chung MW, Jin SK, Kim YS, et al. (2009) Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans. J Clin Pharm Ther 34: 561-567.
40. Kaufman MP, Coleridge HM, Coleridge JC, Baker DG, (1980) Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol 48: 511-517.
41. Morice AH, Lowry R, Brown MJ, Higenbottam T, (1989) Angiotensin-converting enzyme and the cough reflex. Lancet 2: 1116-1118.
42. Just PM, (1989) The positive association of cough with angiotensin converting enzyme inhibitors. Pharmacotherapy 9: 82-87.
43. Tomaki M, Ichinose M, Miura M, Hirayama Y, Kageyama N, et al. (1996) Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P. Thorax 51: 199-201.
44. Morice AH, Turley AJ, Linton TK, (1997) Human ACE gene polymorphism and distilled water induced cough. Thorax 52: 111-113.
45. Ujiie Y, Sekizawa K, Aikawa T, Sasaki H, (1993) Evidence for substance P as an endogenous substance causing cough in guinea pigs. Am Rev Respir Dis 148: 1628-1632.
46. Takahashi T, Yamaguchi E, Furuya K, Kawakami Y, (2001) The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage. Respir Med 95: 130-135.
47. Waeber B, Brunner HR, (1996) Cardiovascular hypertrophy: role of angiotensin II and bradykinin. J Cardiovasc Pharmacol 27: S36-S40.
48. Newnham DM, Hamilton SJ, (1997) Sensitivity of the cough reflex in young and elderly subjects. Age Ageing 26: 185-188.
49. Okaishi K, Morimoto S, Fukuo K, Niinobu T, Hata S, et al. (1999) Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens 12: 778-783.
50. Takahashi T, Morimoto S, Okaishi K, Kanda T, Nakahashi T, et al. (2005) Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene. Am J Hypertens 18: 1353-1359.
51. Nishio K, Kashiki S, Tachibana H, Kobayashi Y, (2011) Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis. World J Cardiol 26: 329-336.